Halozyme Therapeutics (HALO) EBT Margin Growth (5y) (2015 - 2026)
Halozyme Therapeutics (HALO) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Halozyme Therapeutics | 11.25 Bn | 11.02 Bn | 401.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -784.00 |
| Mar 31, 2026 | 1,632.00 |
| Dec 31, 2025 | -8,251.00 |
| Sep 30, 2025 | 628.00 |
| Jun 30, 2025 | 1,606.00 |
| Mar 31, 2025 | 7,833.00 |
| Dec 31, 2024 | 12,401.00 |
| Sep 30, 2024 | 11,101.00 |
| Jun 30, 2024 | 8,821.00 |
| Mar 31, 2024 | 4,583.00 |
| Dec 31, 2023 | 4,699.00 |
| Sep 30, 2023 | 15,608.00 |
| Jun 30, 2023 | 10,708.00 |
| Mar 31, 2023 | 12,056.00 |
| Dec 31, 2022 | -2,512.00 |
| Sep 30, 2022 | 3,005.00 |
| Jun 30, 2022 | 11,031.00 |
| Mar 31, 2022 | 17,399.00 |
| Dec 31, 2021 | 12,503.00 |
| Sep 30, 2021 | 15,082.00 |